Development of a Safeguard System Using an Episomal Mammalian Artificial Chromosome for Gene and Cell Therapy
The development of a safeguard system to remove tumorigenic cells would allow safer clinical applications of stem cells for the treatment of patients with an intractable disease including genetic disorders. Such safeguard systems should not disrupt the host genome and should have long-term stability...
Saved in:
Main Authors: | Narumi Uno (Author), Katsuhiro Uno (Author), Shinya Komoto (Author), Teruhiko Suzuki (Author), Masaharu Hiratsuka (Author), Mitsuhiko Osaki (Author), Yasuhiro Kazuki (Author), Mitsuo Oshimura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microcell-mediated chromosome transfer between non-identical human iPSCs
by: Narumi Uno, et al.
Published: (2024) -
Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling
by: Yasuhiro Kazuki, et al.
Published: (2021) -
Treatment of CHO cells with Taxol and reversine improves micronucleation and microcell-mediated chromosome transfer efficiency
by: Narumi Uno, et al.
Published: (2023) -
Use of a Human Artificial Chromosome for Delivering Trophic Factors in a Rodent Model of Amyotrophic Lateral Sclerosis
by: Yasuhiro Watanabe, et al.
Published: (2015) -
Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells
by: Andoni Gómez-Moreno, et al.
Published: (2023)